NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

ARTICE® Real Data Collection & Observational Trial, Phase 4 Study

RecruitingN/A

Sponsor: Artcline GmbH

Conditions: Sepsis, Septic Shock, Immunoparalysis in Septic Shock

Countries: Germany

The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Subjects ≥ 18 years who are planned to receive ARTICE® treatment during their ICU stay

Exclusion Criteria:

\-

Locations (2)

Magdeburg, Germany
Minden, Germany